Table 2.

Association of blood lactate with the prevalence of MAFLD.

	B statistic	OR	95% CI	p value
Without metformin
Model 1	0.394	1.482	1.344-1.635	<0.001
Model 2	0.372	1.451	1.312-1.605	<0.001
Model 3	0.341	1.406	1.263-1.565	<0.001
Model 4	0.289	1.335	1.197-1.488	<0.001
Model 5	0.270	1.311	1.144-1.501	<0.001
Model 6	0.166	1.181	1.010-1.381	0.037
Metformin
Model 1	0.422	1.525	1.404-1.658	<0.001
Model 2	0.449	1.566	1.438-1.706	<0.001
Model 3	0.451	1.570	1.434-1.719	<0.001
Model 4	0.418	1.519	1.386-1.665	<0.001
Model 5	0.410	1.506	1.341-1.692	<0.001
Model 6	0.320	1.378	1.210-1.569	<0.001

Model 1: unadjusted.

Model 2: Adjusted for age, sex, and DD.

Model 3: Further adjustment for obesity, smoking status, and alcohol drinking.

Model 4: Further adjustment for use of LLD, IIAs, and insulin sensitizers.

Model 5: Further adjustment for WC, WHR, and BMI.

Model 6: Further adjustment for TC, HDL-C, LDL-C, TG, eGFR, SUA, UAE, FPG, 2-h PPG, HbA1c, CRP, FCP, and 2-h PCP.